Screening intention of MTs-DNA test for Colorectal Cancer screening and associated factors among hospital-based populations in southeastern China

Author:

Sun Xiaoyan1,Fan Jinqing2,Zhao Wangfang3,Lu Qiwen3,Gu Jundi3,Lv Lebin1,Gao Hanlu1,Ye Guoliang3

Affiliation:

1. Department of Preventive Health, The Affiliated Hospital of Medical School of Ningbo University.

2. Department of Traditional Chinese Medicine, The Affiliated Hospital of Medical School of Ningbo University

3. Department of Gastroenterology, The Affiliated Hospital of Medical School of Ningbo University.

Abstract

Abstract Background Multi-target stool DNA (MT-sDNA) test can reduce colorectal cancer (CRC) incidence and mortality as a simple, noninvasive screening method. It is crucial to understand people's willingness to accept and willingness to pay for MT-sDNA test for CRC screening. Methods A hospital-based study was conducted in the affiliated hospital of medical school of Ningbo University in southeastern China between June 2021 to March 2022. Individuals aged ≥ 40 years from outpatient department, endoscopy center and inpatient department were included. All participants completed a questionnaire to collect detailed information by a face-to-face interview. Characteristics of individuals were described using frequency and percentage. Group comparisons were performed with chi-square test for categorical variable. Multivariate logistic regression analyses were performed to estimate the associations of social-demographic characteristics, lifestyle factors, CRC risk and medical history with screening intention. Results Of the 977 participants who completed the interview, 85.06% were willing to accept MTs-DNA test for CRC screening, 82.29% were willing to pay for it. Individuals came from non outpatient source (OR = 3.16, 95% CI: 2.14, 4.68), with moderate risk of CRC (OR = 1.66, 95% CI: 1.10, 2.52) were more likely to accept MTs-DNA test for CRC screening. Those came from non outpatient source (OR = 2.56, 95% CI: 1.79, 3.67), with moderate risk of CRC (OR = 1.98, 95% CI: 1.34, 2.91), with history of polypectomy (OR = 2.20, 95% CI: 1.31, 3.68) and with middle/high school education and graduated from college or above (OR = 1.62, 95% CI: 1.07, 2.46, OR = 2.67, 95% CI: 1.27, 5.60, respectively) were more willing to pay for MTs-DNA test for CRC screening. Conclusion The present study found that individuals from non outpatient source, with moderate risk of CRC, with higher education and history of polypectomy were more likely to accept MTs-DNA test or pay for it. It is worth noting that individuals with high risk of CRC were less likely to accept MTs-DNA test and pay for it. Health education interventions should be developed to emphasise the significance of screening and introduce the simple, noninvasive MT-sDNA test to the public, especially those with above characteristics.

Publisher

Research Square Platform LLC

Reference37 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung H;CA,2021

2. Interpretation of global colorectal cancer statistics;Zheng Y;Zhonghua Liu Xing Bing Xue Za Zhi,2021

3. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020;Cao W;Chin Med J,2021

4. Colorectal cancer, screening and primary care: A mini literature review;Hadjipetrou A;World J Gastroenterol,2017

5. On prevention and control stratege of colorectal cancer in China;Chen HD;Chin J Epidemiol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3